Research Topics
| Bruno GuerciSummaryAffiliation: CHU de Nancy Country: France Publications
| Collaborators
|
Detail Information
Publications
Gastric electrical stimulation for the treatment of diabetic gastroparesisB Guerci
Service de Diabetologie, Maladies metaboliques et nutrition, Universite de Nancy I, CIC INSERM, CHU de Nancy, 54511 Vandœuvre les Nancy, France Electronic address
Diabetes Metab 38:393-402. 2012..The enteral route should be preferred (nasojejunal and jejunostomy if possible efficiency). However, in case of failure especially in patients with small bowel neuropathy, the long-term parenteral nutrition is sometimes required...
Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patientsBruno Guerci
Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, CIC INSERM, Hopital Jeanne d Arc, Nancy, France
Diabetes Care 26:1137-41. 2003..This study was designed to test the accuracy of capillary ketonemia for diagnosis of ketosis after interruption of insulin infusion...- [Asymptomatic glycemic instability: how to measure it and which clinical applications? ]B Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul, France
Diabetes Metab 29:179-88. 2003..The evaluation of glucose instability can be provided using new methods of glucose monitoring and could be useful to optimize the therapeutic regimens in some of these diabetic patients... - Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) studyB Guerci
Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, BP 303, Dommartin les Toul, 54201 Toul Cedex, France
Diabetes Metab 29:587-94. 2003..An open label randomized prospective study was designed to compare changes in metabolic control over 6 months in patients managed with usual recommendations alone (conventional assessment group) or combined with SMBG... - [Continuous glucose monitoring: which benefits?]B Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hôpital Jeanne d Arc CHU de Nancy, F 54201 Toul Cedex
Ann Endocrinol (Paris) 65:S59-67. 2004..The different techniques, the studies conducted in children and adult diabetic patients, as well as the main current indications for continuous glucose monitoring are described in this article... - [Glitazones clinical data: an update]B Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, CIC INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, BP 303, France
Ann Endocrinol (Paris) 66:1S45-58. 2005..This review describe and discuss the most recent studies and their results... - Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosisB Guerci
Service de Diabetologie, Maladies metaboliques et nutrition, Hopital Jeanne d Arc, Route Nationale 4, 54201 Dommartin les Toul
Diabetes Metab 31:401-6. 2005..Indeed, it appears more appropriate, simple, descriptive and significant both for health-care staff and for patients... - Subcutaneous insulin: pharmacokinetic variability and glycemic variabilityB Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, France
Diabetes Metab 31:4S7-4S24. 2005.... - Exenatide: its position in the treatment of type 2 diabetesB Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, centre d investigation clinique, Hopital Jeanne d Arc, CHU de Nancy, B P 90303, 54201 Toul Cedex, France
Ann Endocrinol (Paris) 69:201-9. 2008..The aim of this article is to summarize main clinical data on exenatide and to discuss its position in current therapeutic strategy... - [New hypoglycemic agents in type 2 diabetes]Bruno Guerci
Université de Nancy I et service de diabétologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, 54201 Toul BP 90303
Rev Prat 60:495-503. 2010..However their effectiveness and long-term safety need to be evaluated... - Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogsBruno Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Centre d Investigation Clinique INSERM CHU de NANCY Hôpital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul cedex, France
Diabetes Care 26:582-9. 2003..Devices intended for use in the future, such as the continuous glucose monitoring system (CGMS), should satisfy similar criteria, particularly in diabetic patients under intensive therapy... - Analysis of the postprandial lipid metabolism: use of a 3-point testB Guerci
Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, France
Diabetes Metab 27:449-57. 2001..A simplified fat load test could be more convenient and more appropriate in routine clinical practice because of the number of lipid determinations required... - Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitusB Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul, Cedex
Diabetes Metab 27:436-47. 2001..Finally, recent reports indicate that an improved metabolic control in diabetic patients, whatever the treatment used, is associated with near normalization or restoration of normal endothelial function... - Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial functionB Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul Cedex
Diabetes Metab 27:425-34. 2001..Finally, recent reports indicate that an improved metabolic control in diabetic patients, whatever the treatment used, is associated with near normalization or restoration of normal endothelial function... - Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patientsB Guerci
Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, INSERM CHU de Nancy, Hopital Jeanne d Arc, Toul, France
Diabetes Metab 25:412-8. 1999..40, p < 0.05). Lipoprotein(a) appears to be associated with the severity of diabetic retinopathy in Type 1 diabetic patients, and particular attention should be paid to those with Lp(a) above 30 mg/dl and pre-proliferative retinopathy... - The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patientsLaurent Meyer
, , CIC-INSERM, , Centre Hospitalo-Universitaire de Nancy, Toul, France
Diabetes Care 25:2153-8. 2002..069). CONCLUSIONS: Metformin was found to be a safe insulin-sparing agent, when used in combination with CSII for the treatment of type 1 diabetes... - Evolution of analytical performance in portable glucose meters in the last decadePhilip Bohme
Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Hopital Jeanne d Arc, CHU Nancy, France
Diabetes Care 26:1170-5. 2003..To assess and compare the technical accuracy of portable glucose meters during the last decade... - Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patientsB Guerci
Centre d Investigation Clinique INSERM Centre Hospitalier Universitaire de NANCY Hôpital Jeanne d Arc, Toul, France
J Clin Endocrinol Metab 84:2673-8. 1999..Thus, a short interruption of Lispro in CSII is associated with an earlier, greater metabolic deterioration, but Lispro corrected this metabolic deterioration more effectively... - Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxidesB Guerci
Service de Diabetologie, Nutrition et Maladies Metaboliques, Centre Hospitalo Universitaire de Nancy Hôpital Jeanne d Arc, 54201 Toul cedex B P 303, France
Clin Chem 45:1439-48. 1999..The men and women in the diabetic groups were studied separately and matched for age, body mass index, duration of diabetes, glycohemoglobin, and conventional lipid characteristics according to the presence or absence of hyperlipidemia... - [Physiopathology of obesity. Dietary factors, and regulation of the energy balance]O Ziegler
Diabetologie, Maladies metaboliques et nutrition, Centre Hospitalier Universitaire de Nancy, Hopital Jeanne d Arc, 54201 Toul
Ann Endocrinol (Paris) 61:12-23. 2000..There is a need for more longitudinal studies on the role of macronutrient composition, food choice or eating disorders, especially among children, teenagers and young adults... - Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitisD Quilliot
centre d investigation clinique, INSERM CHU, Centre Hospitalo Universitaire de Nancy, France
Pancreas 22:299-306. 2001..We have yet to determine whether the differences in trace-element status contribute to the clinical expression of the disease... - [Macronutrients, fat mass, fatty acid flux and insulin sensitivity]O Ziegler
Service de Diabétologiem Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire de Nancy, 54201 Toul Cedex, France
Diabetes Metab 27:261-70. 2001..Weight loss can induce marked improvement in insulin resistance, but weight maintenance is also required to keep long term good metabolic results... - Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitisD Quilliot
Service de Diabetologie, Maladies metaboliques et nutrition, Hopital Jeanne d Arc, CHU de Nancy, Toul, France
Metabolism 50:1019-24. 2001..As apo A-IV is involved in reverse cholesterol transport, its low level in CP-DM may contribute to the accelerated development of atherosclerosis in these patients... - [The "second atherogenic phenotype" or the role of insulin resistance in vascular risk]O Ziegler
CHU de Nancy, , Toul
Arch Mal Coeur Vaiss 91:33-9. 1998..Therapeutic trials comparing the efficacy of statins and fibrates with respect to cardiovascular and global mortality should provide future information in this debate... - Metformin and insulin in type 1 diabetes: the first stepLaurent Meyer
Diabetes Care 26:1655-6. 2003 - New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndromeAurélie Decaudain
INSERM U680, Paris, F 75012 France
J Clin Endocrinol Metab 92:4835-44. 2007..We report here the phenotypes of the patients with non-codon 482 mutations and compare them with those of 11 patients with codon 482 mutations. We also studied skin fibroblasts or lymphocytes from seven patients... - The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3Christine Bellanne-Chantelot
Département de génétique, Groupe Hospitalier Pitie Salpetriere, Bât 6 rue Lapeyronie, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
Diabetes 57:503-8. 2008..This may be due to environmental and/or genetic factors, including molecular characteristics of the hepatocyte nuclear factor 1-alpha (HNF1A) gene mutation...